Michael Recht/LinkedIn
Nov 26, 2025, 14:52
WFH Committee Member Highlight: Michael Recht on the Effectiveness of Octocog Alfa in Haemophilia A
World Federation of Hemophilia (WFH) shared on LinkedIn:
” Real-world data tell a powerful story.
In a recent study Octocog Alfa (BAY 81-8973) has shown effectiveness for people with hemophilia A, including under-represented groups, in the ATHN dataset.”
WFH has shared a committee member highlight from Michael Recht.
Read the full article here.
Article: Effectiveness of Octocog Alfa (BAY 81-8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under-Represented Subgroups
Authors: Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia